CSIMarket
 


Quest Diagnostics Inc  (DGX)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

DGX's Income from Cont. Operations Growth by Quarter and Year

Quest Diagnostics Inc's Income from Cont. Operations results by quarter and year




DGX Income from Cont. Operations (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December - 609.00 265.00 197.00
III Quarter September - 591.00 226.00 227.00
II Quarter June - 193.00 219.00 233.00
I Quarter March 490.00 106.00 176.00 189.00
FY   490.00 1,499.00 886.00 846.00



DGX Income from Cont. Operations first quarter 2021 Y/Y Growth Comment
Quest Diagnostics Inc achieved in the first quarter, above Company average Income from Cont. Operations surge of 362.26% year on year, to $ 490.00 millions.

Among companies who have reported first quarter results in the Medical Laboratories industry only one Company has achieved higher year on year Income from Cont. Operations results in the first quarter. While Quest Diagnostics Inc' s Income from Cont. Operations doubling of 362.26% ranks overall at the positon no. 42 in the first quarter.




DGX Income from Cont. Operations ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - 129.81 % 34.52 % -26.22 %
III Quarter September - 161.5 % -0.44 % 29.71 %
II Quarter June - -11.87 % -6.01 % 12.56 %
I Quarter March 362.26 % -39.77 % -6.88 % 8 %
FY   - 69.19 % 4.73 % 2.67 %

Financial Statements
Quest Diagnostics Inc's first quarter 2021 Income from Cont. Operations $ 490.00 millions DGX's Income Statement
Quest Diagnostics Inc's first quarter 2020 Income from Cont. Operations $ 106.00 millions Quarterly DGX's Income Statement
New: More DGX's historic Income from Cont. Operations Growth >>


DGX Income from Cont. Operations (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - 3.05 % 17.26 % -13.22 %
III Quarter September - 206.22 % 3.2 % -2.58 %
II Quarter June - 82.08 % 24.43 % 23.28 %
I Quarter March -19.54 % -60 % -10.66 % -29.21 %
FY (Year on Year)   - 69.19 % 4.73 % 2.67 %




Income from Cont. Operations first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #2
Healthcare Sector #2
Overall #42

Income from Cont. Operations Y/Y Growth Statistics
High Average Low
46.2 % 3.1 % -33.42 %
(Sep 30 2020)   (Sep. 30, 2014)
Income from Cont. Operations first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #2
Healthcare Sector #2
Overall #42
Income from Cont. Operations Y/Y Growth Statistics
High Average Low
46.2 % 3.1 % -33.42 %
(Sep 30 2020)   (Sep. 30, 2014)

Income from Cont. Operations by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Quest Diagnostics Inc's Q/Q Income from Cont. Operations Growth


Income from Cont. Operations Q/Q Growth Statistics
High Average Low
206.22 % 9.56 % -64.1 %
(Sep 30 2020)  


DGX's I. Quarter Q/Q Income from Cont. Operations Comment
In the I. Quarter 2021 Quest Diagnostics Inc reported fall in Income from Cont. Operations from the previous quarter by -19.54% to $ 490.00 millions, from $ 609.00 millions declared a quarter before.

If you look into present shortcoming in the I. Quarter 2021, you suppose to take into consideration, that commonly I. Quarter performance occur sluggish in contrast to the quarter before, Lucia Russo, Healthcare sector contributor based in Zurich said.

Within Medical Laboratories industry only one company achieved higher sequential Income from Cont. Operations growth. While Quest Diagnostics Inc's Income from Cont. Operations growth quarter on quarter, overall rank is 107.


Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #2
Healthcare Sector #7
Overall #107
Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #2
Healthcare Sector #7
Overall #107
Income from Cont. Operations Q/Q Growth Statistics
High Average Low
206.22 % 9.56 % -64.1 %
(Sep 30 2020)  


DGX's I. Quarter Q/Q Income from Cont. Operations Comment
In the I. Quarter 2021 Quest Diagnostics Inc realized fall in Income from Cont. Operations sequentially by -19.54% to $ 490.00 millions, from $ 609.00 millions released in the previous quarter.

This is not huge problem, as I. Quarter Income from Cont. Operations always gravitate to plunge in this quarter.

Within Medical Laboratories industry only one company achieved higher sequential Income from Cont. Operations growth. While Quest Diagnostics Inc's Income from Cont. Operations growth quarter on quarter, overall rank is 107.


Quest Diagnostics Inc's 12 Months Income from Cont. Operations Growth Year on Year


Income from Cont. Operations TTM Growth

12 Months Ending
(Mar 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
Cumulative Income from Cont. Operations 12 Months Ending $ 1,883.00 $ 1,499.00 $ 1,155.00 $ 790.00 $ 816.00
Y / Y Income from Cont. Operations Growth (TTM) 130.76 % 69.19 % 41.2 % -3.54 % -2.04 %
Year on Year Income from Cont. Operations Growth Overall Ranking # 165 # 339 # 422 # 940 # 1048
Seqeuential Income from Cont. Operations Change (TTM) 25.62 % 29.78 % 46.2 % -3.19 % -7.9 %
Seq. Income from Cont. Operations Growth (TTM) Overall Ranking # 42 # 155 # 251 # 1061 # 534




Cumulative Income from Cont. Operations growth Comment
With 130.76% annual Income from Cont. Operations growth, Quest Diagnostics Inc would report a record annual Income from Cont. Operations surge if the fiscal year would end on Mar 31 2021.

Among companies within the Healthcare sector 18 other companies have achieved higher trailing twelve month Income from Cont. Operations growth. While Total ranking has impoved so far to 165, from total ranking in previous quarter at 339.

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
46.2 %
3.1 %
-33.42 %
 

Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 2
Healthcare Sector # 19
Overall # 165

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
130.76 %
8.81 %
-35.86 %
(Mar 31 2021)  


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 2
Sector # 2
S&P 500 # 42
Cumulative Income from Cont. Operations growth Comment
With 130.76% annual Income from Cont. Operations growth, Quest Diagnostics Inc would report a record annual Income from Cont. Operations surge if the fiscal year would end on Mar 31 2021.

Among companies within the Healthcare sector 18 other companies have achieved higher trailing twelve month Income from Cont. Operations growth. While Total ranking has impoved so far to 165, from total ranking in previous quarter at 339.

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
46.2 %
3.1 %
-33.42 %
 


Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 2
Healthcare Sector # 19
Overall # 165

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
130.76 %
8.81 %
-35.86 %
(Mar 31 2021)  


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 2
Sector # 2
S&P 500 # 42




Other Income from Cont. Operations Growth
Medical Laboratories Industry Income from Cont. Operations Growth Trends and Statistics
Healthcare Sector Income from Cont. Operations Growth Statistics
Income from Cont. Operations Growth Trends for overall market
DGX's Income from Cont. Operations Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Income from Cont. Operations Growth
Lowest Ranking Income from Cont. Operations Growth
Income from Cont. Operations Growth for DGX's Competitors
Income from Cont. Operations Growth for Quest Diagnostics Inc's Suppliers
Income from Cont. Operations Growth for DGX's Customers

You may also want to know
DGX's Annual Growth Rates DGX's Profitability Ratios DGX's Asset Turnover Ratio DGX's Dividend Growth
DGX's Roe DGX's Valuation Ratios DGX's Financial Strength Ratios DGX's Dividend Payout Ratio
DGX's Roa DGX's Inventory Turnover Ratio DGX's Growth Rates DGX's Dividend Comparisons



Companies with similar Income from Cont. Operations surge for the quarter ending Mar 31 2021 within Healthcare SectorY/Y Change %Income from Cont. Operations for the quarter ending Mar 31 2021
Hologic Inc543.72%$ 543.718 millions
Surmodics Inc 453.15%$ 453.146 millions
Integra Lifesciences Holdings Corp394.49%$ 394.488 millions
Apollo Medical Holdings Inc 384.03%$ 384.031 millions
Quest Diagnostics Inc362.26%$ 362.264 millions
Quidel Corporation342.59%$ 342.588 millions
Progyny Inc 273.82%$ 273.823 millions
Avantor Inc 248.94%$ 248.936 millions
Teva Pharmaceutical Industries Ltd236.00%$ 236.000 millions
Abbott Laboratories229.60%$ 229.596 millions
Repligen Corp200.05%$ 200.051 millions
Reynolds Consumer Products Inc 184.62%$ 184.615 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

GTN's Profile

Stock Price

GTN's Financials

Business Description

Fundamentals

Charts & Quotes

GTN's News

Suppliers

GTN's Competitors

Customers & Markets

Economic Indicators

GTN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071